Doç. Dr. Ant Uzay

Extreme Thrombocytosis in MECOM-Rearranged Acute Myeloid Leukemia: A Diagnostic and Therapeutic Challenge

Indian Journal of Hematology and Blood Transfusion, 2026

DOI 10.1007/s12288-026-02335-5 Kaynak: OpenAlex

BEGEV as Salvage Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma: Real-World Outcomes and Transplantation Feasibility

Medicina, 2026

DOI 10.3390/medicina62081502 PMID 42654399 Açık erişimli tam metinKaynak: OpenAlex

Post-Transplant Lymphoproliferative Disorder After Successful Treatment of Graft-Versus Host Disease Following Liver Transplantation

Transplantation Proceedings, 2026

DOI 10.1016/j.transproceed.2026.09.018 PMID 42881047 Kaynak: OpenAlex

Pulmonary outcomes after hematopoietic stem cell transplantation: A comparative study of autologous and allogeneic recipients

European Respiratory Journal, 2026

DOI 10.1183/13993003.congress-2026.pa630 Kaynak: OpenAlex

The effect of threosulfan-based versus busulfan-based preparation regimens on transplant outcomes

Transfusion and Apheresis Science, 2025

DOI 10.1016/j.transci.2025.104186 PMID 40555163 Kaynak: OpenAlex

A comparison of cyclophosphamide at different dose levels for stem cell mobilization in multiple myeloma

Transfusion and Apheresis Science, 2025

DOI 10.1016/j.transci.2025.104183 PMID 40627978 Kaynak: OpenAlex

A Case of Kappa Light-Chain Multiple Myeloma With Auer Rod-Like Inclusions and Snapper-Schneid Granules

Cureus, 2025

DOI 10.7759/cureus.83170 PMID 40303281 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

C-reactive Protein Guided Empirical Antibiotic Therapy Versus Standardized Neutropenic Fever Approach in Patients Undergoing High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation

Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, 2025

DOI 10.4274/bmj.galenos.2025.2024.12-1 Kaynak: OpenAlex

Does body mass index affect stem cell yield in healthy donors?

Transfusion and Apheresis Science, 2025

DOI 10.1016/j.transci.2025.104181 PMID 40609366 Kaynak: OpenAlex

Is there a relationship between stem cell yield obtained from healthy donors and healthy donors’ blood type?

Transfusion and Apheresis Science, 2025

DOI 10.1016/j.transci.2025.104182 PMID 40627979 Kaynak: OpenAlex

The impact of second allogeneic hematopoietic stem cell transplantation as salvage therapy for hematologic diseases after a first allogeneic transplantation

Transfusion and Apheresis Science, 2025

DOI 10.1016/j.transci.2025.104187 PMID 40543289 Kaynak: OpenAlex

POSTER: CT-376 Does Body Mass Index Affect Stem Cell Yield in Healthy Donors?

Clinical Lymphoma Myeloma & Leukemia, 2025

DOI 10.1016/s2152-2650(25)01406-5 Kaynak: OpenAlex

CT-376: Does Body Mass Index Affect Stem Cell Yield in Healthy Donors?

Clinical Lymphoma Myeloma & Leukemia, 2025

DOI 10.1016/s2152-2650(25)02780-6 Kaynak: OpenAlex

Treosulfan is a safe and effective alternative to busulfan for conditioning in adult allogeneic HSCT patients: Data from a single center

Cancer Medicine, 2024

DOI 10.1002/cam4.7292 PMID 38752476 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

BEGEV is an Effective Therapy for Heavily Pretreated and Platinum-Resistant Relapsed/Refractory Hodgkin’s Lymphoma Patients: A Single Center Real-Life Experience

Indian Journal of Hematology and Blood Transfusion, 2024

DOI 10.1007/s12288-024-01924-6 PMID 41084559 Açık erişimli tam metinKaynak: OpenAlex

Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data

Hematological Oncology, 2023

DOI 10.1002/hon.3174 PMID 37211991 31 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Outcomes of Treosulfan Vs. Busulfan Based Conditioning Regimens in Adult Patients Undergoing Allogeneic HSCT: Real Life Data from a Single Center

Blood, 2023

DOI 10.1182/blood-2023-189049 Kaynak: OpenAlex

Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey

Annals of Hematology, 2022

DOI 10.1007/s00277-022-05052-x PMID 36401621 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

P1227: POLATUZUMAB VEDOTIN, RITUXIMAB, AND BENDAMUSTINE COMBINATION IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-WORLD DATA FROM TURKEY

HemaSphere, 2022

DOI 10.1097/01.hs9.0000847772.34235.05 Açık erişimli tam metinKaynak: OpenAlex

Daily low dose intravesical cidofovir for the treatment of BK virus associated hemorrhagic cystitis after allogeneic stem cell transplantation

Journal of Infection and Chemotherapy, 2022

DOI 10.1016/j.jiac.2022.09.014 PMID 36162643 5 atıf (Europe PMC) Kaynak: OpenAlex

Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data

Blood, 2022

DOI 10.1182/blood-2022-165385 9 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Brentuximab vedotin consolidation therapy after autologous stem‐cell transplantation in patients with high‐risk Hodgkin lymphoma: Multicenter retrospective study

Hematological Oncology, 2021

DOI 10.1002/hon.2897 PMID 34171130 15 atıf (Europe PMC) Kaynak: OpenAlex

HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

Clinical Lymphoma Myeloma & Leukemia, 2021

DOI 10.1016/s2152-2650(21)01845-0 Kaynak: OpenAlex

Poster: HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

Clinical Lymphoma Myeloma & Leukemia, 2021

DOI 10.1016/s2152-2650(21)01484-1 Kaynak: OpenAlex

Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

Kocaeli Üniversitesi - AVESİS, 2021

Kaynak: OpenAlex

Fusariosis manifesting as targetoid purpuric cutaneous lesions in immunocompromised patients

Journal of the European Academy of Dermatology and Venereology, 2020

DOI 10.1111/jdv.16551 PMID 32348587 Açık erişimli tam metinKaynak: OpenAlex

Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease

Transplantation and Cellular Therapy, 2020

DOI 10.1016/j.bbmt.2019.12.757 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Myelodysplastic syndrome with t(9;22)(p24;q11.2), a BCR-JAK2 fusion: case report and review of the literature

International Journal of Hematology, 2015

DOI 10.1007/s12185-015-1792-2 PMID 25833723 11 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

The Prognostic Value of CD49d Expression in Turkish Patients with Chronic Lymphocytic Leukemia

Turkish Journal of Hematology, 2012

DOI 10.5152/tjh.2012.03 8 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Bortezomib in patients with renal impairment

Hematology, 2011

DOI 10.1179/102453311x13025568941880 PMID 21756535 6 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Human herpes virus 8‐unrelated primary effusion lymphoma‐like lymphoma: report of a rare case and review of the literature

Apmis, 2009

DOI 10.1111/j.1600-0463.2008.00005.x PMID 19245595 53 atıf (Europe PMC) Kaynak: OpenAlex

Bortezomib: a new therapeutic option for POEMS syndrome

European Journal Of Haematology, 2009

DOI 10.1111/j.1600-0609.2009.01341.x PMID 19732138 40 atıf (Europe PMC) Kaynak: OpenAlex

Synchronous renal cell carcinoma and multiple myeloma: report of two cases and review of the literature.

PubMed, 2009

PMID 19810147 12 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of the literature

Kaynak: acibadem.com.tr profil sayfası